• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
ZHAO Xiaolin,HAO Lina,ZHANG Yichi.Analysis of 13 cases of Bozhi Glycopeptide Injection ADR[J].Journal Of Pharmaceutical Research,2017,36(5):308-310[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 4291times   Download 3178次 QR Code for this article
Scan with your phone!
13例薄芝糖肽注射液不良反应分析
赵孝林,郝丽娜,张一驰
Font:Larger+|Default|Smaller-
(山东大学齐鲁儿童医院,山东 济南 250022)
摘要:
目的 探讨薄芝糖肽注射液的合理用药。方法 采用回顾性分析法,对笔者所在医院2016 年上报的13 例薄芝糖肽注射液ADR报告及本品说明书,按照患儿年龄、性别、体质量,报告类型、ADR表现、发生ADR时用药次数、发生ADR时用药后的时间、ADR持续时间等方面统计及说明书存在问题进行分析。结果 13 例ADR报告中,患儿的平均年龄为(1.99±1.34)岁,平均体质量为(12.12±4.98)kg,发生ADR时平均用药次数为(4.92±4.35)次,发生ADR时用药后的平均时间为(0.55±0.22)h,ADR平均持续时间为(23.43±30.75)h。结论 薄芝糖肽注射液说明书资料不够完善,建议生产厂家完善本品说明书。本品的临床使用不够规范,建议临床使用本品尽量减少超说明书用药情况,加强用药后观察,做好急救措施,发生严重ADR,立即停药,及时抢救,努力把损害减小到最小。
关键词:  药品不良反应  薄芝糖肽注射液  合理用药
DOI:10.13506/j.cnki.jpr.2017.05.017
基金项目:
Analysis of 13 cases of Bozhi Glycopeptide Injection ADR
ZHAO Xiaolin,HAO Lina,ZHANG Yichi
(Qilu Children's Hospital of Shandong University,Jinan 250022,China)
Abstract:
Objective To discuss the rational use of Bozhi Glycopeptide Injection.Methods Retrospective study was used to analyze 13 cases of Bozhi Glycopeptide Injection ADR reported statistically in 2016 and drug instruction,in accordance with children's age,gender,weight,the type of report,as well as ADR performance,the drug frequency of ADR occurred,the time after drug use of ADR,the duration of ADR etc.Results In the 13 cases of ADR reports,the children's average age was (1.99±1.34) years,the average weight was (12.12±4.98)kg,the average drug frequency of ADR occurred was (4.92±4.35)times,the average time after drug use of ADR occurred was (0.55±0.22)h,the duration of ADR was (23.43±30.75)h.Conclusion Bozhi Glycopeptide Injection information was inadequate,it was recommended that manufacturers should improve the drug instruction.Owing to non-standard use in clinical,we suggested decreasing off-label drug use,enhancing the observation after medication,doing a good first aid treatment.Once serious ADR appear,the agents causing the effects must be stopped and suitable remedies should be introduced immediately,trying best to minimize the seriousness.
Key words:  Adverse drug reaction(ADR)  Bozhi Glycopeptide Injection  Rational drug use
Today's Visits:492    Total Visits:2383211
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.